Clinical trial

Probiotic Lysate (Postbiotic and Metabiotic) Supplementation for Type 2 Diabetes Patients (DELI_Diab Study)

NCT05770076

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-02-01

PhaseNA

Study timeline

Study start (actual)2023-02-01Date precision: day

Registry last updated2024-04-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Obesity, Abdominalunresolved

Insulin Resistanceunresolved

Insulin Sensitivityunresolved

Type2 Diabetesunresolved

Type 2 Diabetes Mellitus in Obeseunresolved

Interventions

Probiotic lysate (postbiotic and metabiotic)DIETARY_SUPPLEMENT

PlaceboDIETARY_SUPPLEMENT

Sponsors & collaborators

Bogomolets National Medical Universitylead sponsor

Taras Shevchenko National University of Kyivcollaborator

Danylo Halytsky Lviv National Medical Universitycollaborator

Center for Innovative Medical Technologies of the National Academy of Sciences of Ukrainecollaborator

Kyiv City Clinical Endocrinology Centercollaborator

MirImmunoFarmcollaborator

Stellar Bioticscollaborator

Mapped research locations

KyivUkraine3 LvivUkraine1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05770076 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.